Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

JP Morgan Reiterates Pediatrix Medical as Buy

J.P. Morgan reiterated its buy rating and $55 price target on Pediatrix Medical (PDX) buy rating and $55 price target. The investment bank sees third quarter earnings per share for Pediatrix in the $0.39-$0.40 range versus previous guidance $0.35-$0.37

Analyst Matthew Ripperger says the stock was down just over 14% on Monday, Oct. 8, on no news and that he doesn't think the stock weakness is warranted. He believes it represents an attractive entry point.

Ripperger remains comfortable with $1.26 2001 EPS estimate and his above-consensus $2.30 2002 EPS forecast (which includes $0.65 in non-cash amortization).

blog comments powered by Disqus